Influence of fatty acid patterns on the intestinal absorption pathway of quercetin in thoracic lymph duct-cannulated rats

British Journal of Nutrition

Volumn 109, Issue 12, 2013, Pages 2147-2153

  Murota, Kaeko ^a,b   Cermak, Rainer ^c   Terao, Junji ^b   Wolffram, Siegfried ^d  

^a KINKI UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

^c UNIVERSITY OF LEIPZIG   (Germany)

^d UNIVERSITY OF KIEL   (Germany)

Author keywords

Long chain TAG; Lymph; Medium chain TAG; Quercetin

Indexed keywords

CHYLOMICRON; FLAVONOL; GLUCOSE; ISORHAMNETIN; LONG CHAIN FATTY ACID; MEDIUM CHAIN FATTY ACID; QUERCETIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; AREA UNDER THE CURVE; ARTICLE; BIOAVAILABILITY; CONTROLLED STUDY; DUODENUM; EMULSION; FAT INTAKE; FOOD COMPOSITION; INTESTINE ABSORPTION; MALE; MAXIMUM PLASMA CONCENTRATION; METABOLISM; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; RAT; SOLUBILITY; THORACIC DUCT; TIME TO MAXIMUM PLASMA CONCENTRATION;

ANALYSIS OF VARIANCE; ANIMALS; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; BIOLOGICAL TRANSPORT; CATHETERIZATION; CHYLOMICRONS; FATTY ACIDS; INTESTINAL ABSORPTION; LYMPH; MALE; QUERCETIN; RATS; RATS, WISTAR; TRIGLYCERIDES;

RATTUS;

EID: 84878417307     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114512004564     Document Type: Article

References (18)

1. Cermak R (2008) Effect of dietary flavonoids on pathways involved in drug metabolism. Expert Opin Drug Metab Toxicol 4, 17-35. (Pubitemid 351234098)
2. Murota K & Terao J (2003) Antioxidative flavonoid quercetin: implication of its intestinal absorption and metabolism. Arch Biochem Biophys 417, 12-17. (Pubitemid 36960043)
3. Lesser S, Cermak R & Wolffram S (2004) Bioavailability of quercetin in pigs is influenced by the dietary fat content. J Nutr 134, 1508-1511. (Pubitemid 38720730)
4. Crespy V, Morand C, Besson C, et al. (2003) The splanchnic metabolism of flavonoids highly differed according to the nature of the compound. Am J Physiol Gastrointest Liver Physiol 284, G980-G988. (Pubitemid 36597341)
5. Murota K & Terao J (2005) Quercetin appears in the lymph of unanesthetized rats as its phase II metabolites after administered into the stomach. FEBS Lett 579, 5343-5346. (Pubitemid 41395154)
6. Harkins RW & Sarett HP (1968) Medium-chain triglycerides. JAMA 203, 272-274.
7. Lesser S, Cermak R & Wolffram S (2006) The fatty acid pattern of dietary fat influences the oral bioavailability of the flavonol quercetin in pigs. Br J Nutr 96, 1047-1052. (Pubitemid 46470167)
8. Spayd RW, Bruschi B, Burdick BA, et al. (1978) Multilayer film elements for clinical analysis: applications to representative chemical determinations. Clin Chem 24, 1343-1350. (Pubitemid 8392014)
9. Azuma K, Ippoushi K, Ito H, et al. (2002) Combination of lipids and emulsifiers enhances the absorption of orally administered quercetin in rats. J Agric Food Chem 50, 1706-1712. (Pubitemid 34233251)
10. de Boer VC, Dihal AA, van der Woude H, et al. (2005) Tissue distribution of quercetin in rats and pigs. J Nutr 135, 1718-1725. (Pubitemid 40980724)
11. Morand C, Crespy V, Manach C, et al. (1998) Plasma metabolites of quercetin and their antioxidant properties. Am J Physiol 275, R212-R219.
12. Azuma K, Ippoushi K, Ito H, et al. (2003) Enhancing effect of lipids and emulsifiers on the accumulation of quercetin metabolites in blood plasma after the short-term ingestion of onion by rats. Biosci Biotechnol Biochem 67, 2548-2555. (Pubitemid 39251607)
13. Cermak R, Landgraf S & Wolffram S (2003) The bioavailability of quercetin in pigs depends on the glycoside moiety and on dietary factors. J Nutr 133, 2802-2807. (Pubitemid 37099763)
14. Day AJ, DuPont MS, Ridley S, et al. (1998) Deglycosylation of flavonoid and isoflavonoid glycosides by human small intestine and liver beta-glucosidase activity. FEBS Lett 436, 71-75. (Pubitemid 28454609)
15. Ioku K, Pongpiriyadacha Y, Konishi Y, et al. (1998) Betaglucosidase activity in the rat small intestine toward quercetin monoglucosides. Biosci Biotechnol Biochem 62, 1428-1431. (Pubitemid 128473391)
16. van der Woude H, Boersma MG, Vervoort J, et al. (2004) Identification of 14 quercetin phase II mono-and mixed conjugates and their formation by rat and human phase II in vitro model systems. Chem Res Toxicol 17, 1520-1530. (Pubitemid 39532321)
17. Porter CJ, Kaukonen AM, Boyd BJ, et al. (2004) Susceptibility to lipase-mediated digestion reduces the oral bioavailability of danazol after administration as a medium-chain lipidbased microemulsion formulation. Pharm Res 21, 1405-1412. (Pubitemid 39149655)
18. Porter CJ, Kaukonen AM, Taillardat-Bertschinger A, et al. (2004) Use of in vitro lipid digestion data to explain the in vivo performance of triglyceride-based oral lipid formulations of poorly water-soluble drugs: studies with halofantrine. J Pharm Sci 93, 1110-1121. (Pubitemid 38529685)